IMMUNEERING TO COLLABORATE WITH ASTELLAS ON CLINICAL STUDIES OF INVESTIGATIONAL CLDN18.2 PROGRAMS IN COMBINATION WITH ATEBIMETINIB FOR PANCREATIC CANCER PATIENTS

Reuters · 2d ago

Please log in to view news